PBP Company Profile: Directors, Insiders & Operations | Probiotec | Shorted

⌘K

PBP

Pharmaceuticals, Biotechnology & Life Sciences

Probiotec

Short interest: 0.07%; +0.07 pp 30d; as of 17 June 2024
Reported shorts: 57.4K
Shares on issue: 81.323M

Director trades

10 trades recorded

Date	Director	Type	Shares	Price	Value
2024-06-18	Wesley Stringer	sell	6,336,079	$3.000	$19,008,237
2024-06-18	Jonathan Wenig	sell	115,751	$3.000	$347,253
2024-06-18	Simon Gray	sell	60,000	$3.000	$180,000
2024-06-18	Simon Gray	buy	-	-	-
2024-06-18	Jonathan Wenig	buy	-	-	-
2024-06-18	Wesley Stringer	buy	-	-	-
2024-06-13	Unknown Director	buy	-	-	-
2024-06-06	Wesley Stringer	exercise options	1,400,000	-	-
2024-01-16	Unknown Director	buy	-	-	-
2024-01-12	Wes Stringer	sell	259,794	$2.875	$746,969.89

PBP intelligence dossier

Public-source evidence for this company, with industry drill-up links.

Tax paid and taxable income records
Government contracts and public money
Emissions and trade exposure
Political donations and lobbying links

Sign in to unlock the dossierFree account · no card required